Viva Cyte Systema Programmatum Complexum ab Livia Stevenin

Opus Viva Cyte Systema Programmatum Complexum a designatore Livia Stevenin est victor maxime honoratus praemii praestigiosissimi 2025 Praemium A' Design Award Argenteum in Categoria Certaminis Designatio Interfaciei.

ArgentumInterfacies· 2025

Viva Cyte Systema Programmatum Complexum

a Livia Stevenin

Cliens: Cellply

Victor praemii Praemium A' Design Award Argenteum in Categoria Interfacies

56,621

Victor Praemii Verificatus

Verifica Statum Praemii pro #168358

Visita Situm Vide apud A' Design Award Communicatum Insigne Praemii

Colores

Designum

De Viva Cyte Systema Programmatum Complexum

Viva Cyte est planum programmatum provectum ad evolutionem therapiae cellularis expediendum compositum, automationem, analysim magnae capacitatis et experientiam utentis intuitivam integrans. Constat Programmate Regulandi (CSW) ad experimenta biologica administranda et Programmate Analytico (ASW) ad perceptiones significantes extrahendas. Automatio ab Intelligentia Artificiali impulsa errores humanos minuit, accurationem auget et facilitatem usus meliorat, investigatoribus permittens ut processus operandi complexos efficaciter administrent dum progressiones therapeuticas accelerant.

Agnitio

De Praemium A' Design Award Argenteum

Viva Cyte Systema Programmatum Complexum victor est Praemii A' Design Award Argenteum, honoris eximie amplissimi formis summi generis, pulchris et conspicuis dati. Victores Argenti opera valde splendida et creandi ingenio praedita sunt, quae praestantem peritiam, talentum et acumen auctorum suorum ostendunt. Exspectatur Viva Cyte Systema Programmatum Complexum opus mirabile, exemplare, valde professionale et penitus novum fore. Haec forma Argento victa inventum notabile et admiratum est, quod ad fines artis, scientiae, formandi rationis et technologiae promovendos confert. Viva Cyte Systema Programmatum Complexum creatio est, quam multi invident, quae cupiditates excitat, sensus bonos affert et admirationem miraculumque movet.

Post Designum

Fasciculus Nuntii

Merita, sodales gregis et singula technica a designatore praebita.

Proprietates Singulares: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Dimensiones et Involucrum: Design: Figma
Front-end: React JS
Design System: Bento
Notulae: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Technologia Productionis: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Provocatio Designandi: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Investigatio: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Inspiratio: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Duratio Operis: The project started in January 2022 in Milan and finished in August 2024.
Cursus Operationis: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Membra Turmae: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Agnitiones Imaginum: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),